Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Netherlands Donor Stool Bank (NDFB) is a national facility based at the Leiden University Medical Center (LUMC) that provides standardized, screened donor stool for Fecal Microbiota Transplantation (FMT). Established in 2016, the organization focuses on treating patients with recurrent Clostridioides difficile infections across the Netherlands. Beyond clinical service, the NDFB supports scientific research into the role of the gut microbiome in various diseases, including inflammatory bowel disease and metabolic disorders. The bank operates under strict protocols for donor screening and product preparation to ensure safety and efficacy. It serves as a centralized resource for hospitals nationwide, facilitating access to life-saving microbial therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Netherlands national stool bank.